US Patent 8747813 Inhalable epinephrine
Patent 8747813 was granted and assigned to Civitas Therapeutics on June, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08747813 Inhalable epinephrine US Patent 8747813 Inhalable epinephrine
Infobox
Patent Number
0874781300
Patent Number
874781300
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
087478130
Date of Patent
June 10, 2014
0Patent Application Number
137870260
Date Filed
March 6, 2013
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
087478130
Date of Patent
June 10, 2014
0Patent Application Number
137870260
Date Filed
March 6, 2013
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08747813 Inhalable epinephrine
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08747813
Date of patent
June 10, 2014
Patent application number
13787026
Date Filed
March 6, 2013
Patent primary examiner
Find more entities like US Patent 8747813 Inhalable epinephrine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
